WO1999001155A1
(fr)
*
|
1997-07-04 |
1999-01-14 |
Fujisawa Pharmaceutical Co., Ltd. |
Cephalo-protecteur
|
US6133308A
(en)
|
1997-08-15 |
2000-10-17 |
Millennium Pharmaceuticals, Inc. |
Synthesis of clasto-lactacystin beta-lactone and analogs thereof
|
US7175679B2
(en)
|
2001-03-29 |
2007-02-13 |
Biotempt B.V. |
Oligopeptide treatment of NF-κB mediated inflammation
|
US8680059B2
(en)
*
|
1998-05-20 |
2014-03-25 |
Biotempt B.V. |
Oligopeptide acetate and formulations thereof
|
EP1138692A1
(en)
|
2000-03-29 |
2001-10-04 |
Erasmus Universiteit Rotterdam |
Fragments of human chorionic gonadotropin (hcg) as immunoregulator
|
US6921751B1
(en)
|
1998-05-20 |
2005-07-26 |
Erasmus Universiteit Rotterdam |
Immunoregulator
|
US20030220258A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Robbert Benner |
Treatment of ischemic events
|
US6844315B2
(en)
*
|
1998-05-20 |
2005-01-18 |
Erasmus Universiteit Rotterdam |
Immunoregulator
|
US20090042807A1
(en)
*
|
1998-05-20 |
2009-02-12 |
Nisar Ahmed Khan |
Oligopeptide treatment of ischemia reperfusion injury
|
EP1223948A2
(en)
*
|
1999-09-13 |
2002-07-24 |
CHARLOTTE-MECKLENBURG HOSPITAL doing business as Carolinas Medical Center |
Method of inhibiting nf-kappa-b with heparin, for treating cardiovascular diseases and inflammations
|
US7358330B2
(en)
|
2001-03-29 |
2008-04-15 |
Biotempt B.V. |
Immunoregulatory compositions
|
USRE43279E1
(en)
|
2000-03-29 |
2012-03-27 |
Biotemp B.V. |
Compositions capable of reducing elevated blood urea concentration
|
US7576174B2
(en)
|
2000-03-29 |
2009-08-18 |
Biotempt B.V. |
Compositions capable of reducing elevated blood urea concentration
|
EP1300418A1
(en)
|
2001-10-04 |
2003-04-09 |
Erasmus Universiteit Rotterdam |
Gene regulation by oligopeptides
|
US6713459B1
(en)
*
|
2000-04-28 |
2004-03-30 |
East Tennessee State University |
Methods for the prophylactic and therapeutic treatment of cardiac tissue damage
|
WO2002047610A2
(en)
*
|
2000-11-16 |
2002-06-20 |
The Regents Of The University Of California |
Marine actinomycete taxon for drug and fermentation product dicovery
|
DK1355910T3
(da)
|
2001-01-25 |
2011-06-27 |
Us Of America Represented By The Secretary Dept Of Health And Human Services |
Formulering af borsyreforbindelser
|
DE60218153T2
(de)
|
2001-05-21 |
2007-06-28 |
Alcon Inc. |
Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
|
US7112588B2
(en)
|
2001-05-21 |
2006-09-26 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
DK1448205T3
(da)
*
|
2001-10-05 |
2011-12-12 |
Zalicus Inc |
Kombinationer til behandling af immunoinflammatoriske sygdomme
|
JP4511183B2
(ja)
*
|
2001-12-10 |
2010-07-28 |
デュ,ヤンシェン |
神経変性疾患および心臓血管疾患の治療
|
US20080318871A1
(en)
*
|
2001-12-21 |
2008-12-25 |
Khan Nisar A |
Treatment of neurological disorders
|
US7501391B2
(en)
|
2001-12-21 |
2009-03-10 |
Biotempt B.V. |
Treatment of transplant survival
|
US20080242837A1
(en)
*
|
2001-12-21 |
2008-10-02 |
Khan Nisar A |
Peptide compositions
|
US7786084B2
(en)
*
|
2001-12-21 |
2010-08-31 |
Biotempt B.V. |
Treatment of burns
|
US7176232B2
(en)
|
2002-06-24 |
2007-02-13 |
The Regents Of The University Of California |
Salinosporamides and methods for use thereof
|
US7517529B2
(en)
*
|
2003-04-08 |
2009-04-14 |
Biotempt B.V. |
Treatment of type I diabetes
|
US20050004164A1
(en)
*
|
2003-04-30 |
2005-01-06 |
Caggiano Thomas J. |
2-Cyanopropanoic acid amide and ester derivatives and methods of their use
|
ZA200600473B
(en)
|
2003-06-20 |
2007-04-25 |
Univ California |
Salinosporamides and methods for use thereof
|
DE602004031614D1
(de)
|
2003-06-20 |
2011-04-14 |
Nereus Pharmaceuticals Inc |
Verwendung von (3.2.0) heterocyclischen verbindungen und ihren analoga zur behandlung von krebs
|
WO2005023187A2
(en)
*
|
2003-08-28 |
2005-03-17 |
Kem David C |
Inhibitor of cardiac tachyarrhythmias
|
US20090227505A1
(en)
*
|
2004-01-07 |
2009-09-10 |
Biotempt B.V. |
Methods and uses for protein breakdown products
|
SE0400399D0
(sv)
*
|
2004-02-20 |
2004-02-20 |
Index Pharmaceuticals Ab |
Methods and compositions for the treatment or prevention of secondary ischemic injury
|
US7579371B2
(en)
|
2004-04-30 |
2009-08-25 |
Nereus Pharmaceuticals, Inc. |
Methods of using [3.2.0] heterocyclic compounds and analogs thereof
|
BRPI0509824A
(pt)
*
|
2004-04-30 |
2007-10-09 |
Nereus Pharmaceuticals Inc |
compostos heterocìclicos [3.2.0] e métodos de uso dos mesmos
|
US7425580B2
(en)
*
|
2004-05-19 |
2008-09-16 |
Wyeth |
(Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
|
EP1771194A2
(en)
*
|
2004-07-07 |
2007-04-11 |
Biodevelops Pharma Entwicklung GmbH |
Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface
|
US20060008454A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Dr. Helmut Brunar |
Use of a compound for enhancing the expression of membrane proteins on the cell surface
|
CA2578202C
(en)
*
|
2004-08-30 |
2013-12-17 |
Toray Industries, Inc. |
Fractionation apparatus
|
WO2006062732A2
(en)
*
|
2004-11-19 |
2006-06-15 |
Synta Pharmaceuticals Corp. |
Compounds acting at the centrosome
|
CN103230394B
(zh)
*
|
2004-12-03 |
2016-04-20 |
达纳-法伯癌症研究公司 |
治疗肿瘤性疾病的化合物及其用途
|
KR20080033331A
(ko)
*
|
2005-07-05 |
2008-04-16 |
바이오템프트, 비.브이. |
종양 치료제
|
WO2007002972A2
(en)
*
|
2005-07-06 |
2007-01-11 |
Biodevelops Pharma Entwicklung Gmbh |
Use of a compound for enhancing the expression of membrane proteins on the cell surface
|
CA2614959A1
(en)
*
|
2005-07-14 |
2007-01-25 |
Myogen, Inc. |
Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart
|
US7691896B2
(en)
*
|
2005-08-10 |
2010-04-06 |
President And Fellows Of Harvard College |
Analogs of salinosporamide A
|
EP1864692A1
(en)
|
2006-06-07 |
2007-12-12 |
Biotempt B.V. |
Use of peptides for the control of radiation injury
|
ES2293834B1
(es)
*
|
2006-07-20 |
2009-02-16 |
Consejo Superior Investig. Cientificas |
Compuesto con actividad inhibidora de las interacciones ubc13-uev, composiciones farmaceuticas que lo comprenden y sus aplicaciones terapeuticas.
|
WO2008095195A2
(en)
*
|
2007-02-02 |
2008-08-07 |
Nereus Pharmaceuticals, Inc. |
Lyophilized formulations of salinosporamide a
|
DK2120991T3
(da)
*
|
2007-02-12 |
2014-04-28 |
Biotempt Bv |
Behandling af traumatisk blødning med korte oligopeptider
|
WO2008137780A2
(en)
*
|
2007-05-04 |
2008-11-13 |
Nereus Pharmaceuticals, Inc. |
Use of [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases
|
US7442830B1
(en)
|
2007-08-06 |
2008-10-28 |
Millenium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
US8394816B2
(en)
|
2007-12-07 |
2013-03-12 |
Irene Ghobrial |
Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia
|
EP2276765A4
(en)
|
2008-05-12 |
2011-10-19 |
Nereus Pharmaceuticals Inc |
SALINOSPORAMIDE DERIVATIVES AS PROTEASOMAL HEMMER
|
EP2733147A1
(en)
|
2008-06-17 |
2014-05-21 |
Millennium Pharmaceuticals, Inc. |
Boronate ester compounds and pharmaceutical compositions thereof
|
AR075090A1
(es)
|
2008-09-29 |
2011-03-09 |
Millennium Pharm Inc |
Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
|
EP2305285A1
(en)
|
2009-09-29 |
2011-04-06 |
Julius-Maximilians-Universität Würzburg |
Means and methods for treating ischemic conditions
|
EP2527434B1
(en)
|
2010-01-22 |
2017-08-09 |
Japan Science and Technology Agency |
Probe reagent for measurement of proteolytic activity
|
KR20130036228A
(ko)
|
2010-03-31 |
2013-04-11 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
1-아미노-2-사이클로프로필에틸보론산의 유도체
|
HUE053247T2
(hu)
|
2012-05-09 |
2021-06-28 |
Cantex Pharmaceuticals Inc |
Mieloszuppresszió kezelése
|
US10023611B2
(en)
|
2013-04-16 |
2018-07-17 |
Cipla Limited |
Process for the preparation of bortezomib mannitol ester
|
WO2015117136A1
(en)
|
2014-02-03 |
2015-08-06 |
Ohio State Innovation Foundation |
Boronic acid esters and pharmaceutical formulations thereof
|
WO2015179443A1
(en)
|
2014-05-20 |
2015-11-26 |
Millennium Pharmaceuticals. Inc. |
Boron-containing proteasome inhibitors for use after primary cancer therapy
|
WO2016133910A1
(en)
|
2015-02-17 |
2016-08-25 |
Cantex Pharmaceuticals, Inc. |
Treatment of cancers and hematopoietic stem cell disorders privileged by cxcl12-cxcr4 interaction
|
US20180243217A1
(en)
|
2015-03-17 |
2018-08-30 |
Leon-Nanodrugs Gmbh |
Nanoparticles comprising a stabilized boronic acid compound
|
EP3700567A4
(en)
|
2017-10-26 |
2021-09-29 |
The Regents of The University of California |
INHIBITION OF OXIDATION SPECIFIC EPITOPES FOR TREATMENT OF ISCHEMIC REPERFUSION DAMAGE
|